Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Drug delivery systems (immunoconjugates. Found 2 abstracts

Adams GP, Simmons HH, Yuan Q, Marasco W, Mehta S. Anti-Mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer. 2005 Jul 08;:80 pp.
Robinson MK, Doss M, Shaller C, Narayanan D, Marks JD, Adler LP, Trotter DE, Adams GP. Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody. Cancer Research. 2005 Jan;65(4):1471-8.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Drug delivery systems (immunoconjugates

Drug delivery systems (immunoconjugates antibody conjugated with Pseudomonas (exotoxin PRP (Properties) Antibodies and Immunoglobulins Role: BPN (Biosynthetic preparation)-THU (Therapeutic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (single chain-Fv-anti-MISIIR Lung anti-Mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer) Diagnosis (cancer Positron-emission tomography (immuno-positron emission tomog imaging of HER2-pos tumors with iodine-124 labeled anti-HER2 diabody) unclassified) Toxins Role: BSU (Biological study-BIOL (Biological study) (diphtheria-antibody conjugated with aspirate Mammary gland (nipple Ricins Testis (treatment of Bacteriophage PET immunoimaging tumor HER2 iodine 124 anti HER2 diabody Human unclassified) Proteins Role: BSU (Biological study-BIOL (Biological study) (RIP (ribosome-inactivating protein)-antibody conjugated with Imaging (tumor Tomography (contrast agents Imaging agents cDNA sequences (anti-Mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer) mullerian inhibiting substance receptor MISIIR immunoconjugate human cancer Prostate gland Blood plasma Blood Peptide nucleic acids Viral vectors antibody conjugated with Drug delivery systems (prodrugs Antitumor agents Lung (toxicity Blood cell Plasmid vectors unclassified) Antibodies and Immunoglobulins Role: BSU (Biological study-THU (Therapeutic use)-BIOL (Biological study)-USES (Uses) (labeled Urine Chemotherapy (antibody conjugated with treatment of Carcinoma (cervix Mammary gland unclassified) Hormone receptors Role: BSU (Biological study-BIOL (Biological study) (Mullerian-inhibiting hormone-type II PRP (Properties) Antibodies and Immunoglobulins Role: BPN (Biosynthetic preparation)-THU (Therapeutic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (anti-MISIIR unclassified) Proteins Role: BSU (Biological study-BIOL (Biological study) (momordins-antibody conjugated with Abrins Testis Ovary Cosmids Gene therapy Drug delivery systems (immunotoxins carcinoma Uterus (cervix-treatment of immuno-positron emission tomog imaging of HER2-pos tumors with iodine-124 labeled anti-HER2 diabody) Radionuclides tomog Imaging agents (contrast unclassified) neu Role: BSU (Biological study-BIOL (Biological study) (immuno-positron emission tomog imaging of HER2-pos tumors with iodine-124 labeled anti-HER2 diabody) magnetic Spheres (beads-antibody conjugated with unclassified) Proteins Role: BSU (Biological study-BIOL (Biological study) (PAP (pokeweed antiviral protein)-antibody conjugated with or (MISIIR) immunoconjugates to detect and treat cancer) unclassified) Toxins Role: BSU (Biological study-BIOL (Biological study) (antibody conjugated with PKT (Pharmacokinetics) Antibodies and Immunoglobulins Role: DGN (Diagnostic use)-BIOL (Biological study)-USES (Uses) (monoclonal-124I-labeled Uterus (cervix anti-Mullerian inhibiting substance type II recep
Last updated on Saturday, July 04, 2020